<

 
Data updated 2025-05-13 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date14155459.2 (espacenet)  (Federated)  (European Patent Register), 20100329
Patent/reg. no. and dateDK/EP 2732818, 20170503
Publication date20140521
Priority no. and dateUS 165447 P, 20090331, US 165419 P, 20090331
EP pub. no. and date EP 2732818 20140521
Effective date
Applicant/ownerLigand Pharmaceuticals Inc., 3911 Sorrento Valley Boulevard
Suite 110
San Diego, CA 92121 , US
Applicant ref. no.P4632DKEP
InventorZhang, Jinkun, 11496 Tree Hollow Lane
San Diego, CA California 92128, US,
Dziewanowska, Zofia E, 765 Bonair Place
La Jolla, CA California 92037, US,
Belder, Rene, 579 Province Line Road
Hopewell, NJ New Jersey 08525, US,
Henderson, Ian, 5220 Fiore Terrace, No. 405
San Diego, CA California 92122, US,
Bogardus, Joseph B, 892 Hurricane Road
Keene, NY New York 12942, US,
Zhang, Zhaoying, 20 El Dorado Way
Monroe NJ 08831, US
RepresentativeHØIBERG P/S, Adelgade 12, 1304 København K
Opponent
IPC ClassA61K 31/422 (2006.01) , A61K 9/20 (2006.01) , A61P 13/12 (2006.01) , A61P 9/12 (2006.01) , C07D 413/12 (2006.01) 
TitleBiphenylsulfonamidendothelin- og angiotension II-receptorantagonist til behandling af glomerulosklerose
Int. application no.
Int. publication no.
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact